Asha Moudgil, MD, completed her training in Pediatric Nephrology and Transplant Immunology at Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA. Dr. Moudgil's main interest and focus is on the long-term care of children after renal transplantation and those with difficult nehrotic syndrome. Dr. Moudgil has specialized in several issues pertaining to children after receiving a transplant such as "identifying nutritional vitamin D deficiency and monitoring for bone health", monitoring for "cardiovascular health" and "monitoring for common viruses including Epstein Barr Virus that can cause a cancer in children after transplantation known as post-transplant lymphoproliferative disorder".
Dr. Moudgil focuses on educational efforts for trainees at Children's National Health System and for Pediatric Nephrologists and transplant professionals across the United States and India by participating in writing of National Guidelines, organizing educational conferences and as a visiting faculty for Annual meetings of Indian Society of Pediatric Nephrology. Dr. Moudgil is an avid advocate of patients with kidney diseases. She is a member of the Medical Steering Committee of National Kidney Foundation of National Capitol Area and regularly volunteers in kidney prevention screening programs and educational forums organized by National Kidney Foundation. Dr. Moudgil is a member of several national committees including Pediatric Transplant Community of Practice, American Society of Transplantation; Co-chair, Donor Advocacy Group, Pediatric Transplant Community of Practice, American Society of Transplantation; Special Studies Committee of the North American Pediatric Renal Trials and Collaborative Studies; Member, Clinical Affairs Committee, American Society of Pediatric Nephrology. Dr. Moudgil has published 71 articles and several book chapters related to pediatric kidney disease and transplantation.
Research & Publications
Research & Publications
IPEX syndromean unusual cause of proteinuria in infancy
(2007) Pediatr Nephrol
Cinacalcet is efficacious and safe in pediatric dialysis patients
(2008) Pediatr Nephrol
Clinical significance of peripheral blood EpsteinBarr viral load monitoring using polymerase chain reaction in renal transplant recipients
(2008) Pediatric Transplant
Antierythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient
(2010) Pediatr Nephrol.
Efficacy and safety of treatment with rituximab for difficult steroid resistant and dependent nephrotic syndrome Multicentric report
(2010) Clin J Am Soc Nephrol
See More on PubMed